Aktionsplan Aadi Bioscience, Inc.
Erweiterter Zeitplan
Einfaches Diagramm
Über das Unternehmen Aadi Bioscience, Inc.
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus bound to albumin. The company is also involved in evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.| IPO date | 2017-08-08 |
|---|---|
| ISIN | US00032Q1040 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://aadibio.com |
| Цена ао | 2.02 |
| Preisänderung pro Tag: | 0% (2.02) |
|---|---|
| Preisänderung pro Woche: | 0% (2.02) |
| Preisänderung pro Monat: | -23.48% (2.64) |
| Preisänderung über 3 Monate: | -37.07% (3.21) |
| Preisänderung über sechs Monate: | -1.94% (2.06) |
| Preisänderung pro Jahr: | -13.68% (2.34) |
| Preisänderung über 3 Jahre: | -89.02% (18.39) |
| Preisänderung über 5 Jahre: | +215.13% (0.641) |
| Preisänderung seit Jahresbeginn: | -37.07% (3.21) |
|
|
Unterschätzung
|
Effizienz
|
|||||||||||||||||||||||||||||||||||||
Dividenden
|
Pflicht
|
Wachstumsimpuls
|
|||||||||||||||||||||||||||||||||||||
| Institutionen | Volumen | Aktie, % |
|---|---|---|
| Avoro Capital Advisors LLC | 2849402 | 11.6 |
| Acuta Capital Partners LLC | 1849402 | 7.53 |
| Alerce Investment Management, L.P. | 1630830 | 6.64 |
| Blackrock Inc. | 1081631 | 4.41 |
| Vanguard Group Inc | 859697 | 3.5 |
| Decheng Capital LLC | 526329 | 2.14 |
| Decheng Capital Management III (Cayman), LLC | 526329 | 2.14 |
| Morgan Stanley | 510671 | 2.08 |
| Vivo Capital, LLC | 509572 | 2.08 |
| Citadel Advisors Llc | 407722 | 1.66 |
| ETF | Aktie, % | Rentabilität für das Jahr, % | Dividenden, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.00821 | 17.09 | 1.54048 |
| 0.01 | 17.09 | 1.54 |
| Aufsicht | Berufsbezeichnung | Zahlung | Geburtsjahr |
|---|---|---|---|
| Dr. Neil P. Desai Ph.D. | Founder & Executive Chairman | 710.35k | 1965 (60 Jahre) |
| Dr. Loretta M. Itri F.A.C.P., M.D. | Chief Medical Officer | 617.45k | 1950 (75 Jahre) |
| Mr. David J. Lennon Ph.D. | President, CEO & Director | 277.75k | 1971 (54 Jahr) |
| Mr. Scott M. Giacobello CPA | CFO, Treasurer, Investor Relations & Corporate Communications | 643.23k | 1970 (55 Jahre) |
| Mr. Stephen M. Rodin J.D. | Senior VP of Legal & General Counsel | N/A | 1976 (49 Jahre) |
| Mr. Raymond G. Steitz | Senior VP of Human Resources & Chief Human Resources Officer | N/A | 1959 (66 Jahre) |
| Mr. Bryan Ball | Chief Technical Operations Officer | N/A | 1970 (55 Jahre) |
Adresse: United States, Pacific Palisades. CA, 17383 Sunset Boulevard - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://aadibio.com
Webseite: https://aadibio.com
